{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:45:02Z","timestamp":1761767102565},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>With advancements in cancer treatment, the life expectancy of oncology patients has improved. Thus, transcatheter aortic valve replacement (TAVR) may be considered as a feasible option for oncology patients with severe symptomatic aortic stenosis (AS). We aim to evaluate the difference in short- and long-term all-cause mortality in cancer and non-cancer patients treated with TAVR for severe AS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Medline, PubMed, and Cochrane Central Register of Controlled Trials were searched for relevant studies. Patients with cancer who underwent treatment with TAVR for severe AS were included and compared to an identical population without cancer. The primary endpoints were short- and long-term all-cause mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 899 studies included, 8 met inclusion criteria. Cancer patients had significantly higher long-term all-cause mortality after TAVR when compared to patients without cancer (risk ratio [RR] 1.43; 95% confidence interval (CI) 1.26\u20131.62;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Four studies evaluated short-term mortality after TAVR and demonstrated no difference in it in patients with and without cancer (RR 0.72; 95% CI 0.47\u20131.08;<jats:italic>P<\/jats:italic>\u2009=\u20090.11).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with cancer and severe AS have higher long-term all-cause mortality after TAVR. However, we found no difference in short-term all-cause mortality when comparing patients with and without cancer. The decision to perform TAVR in cancer patients should be individualized based on life expectancy and existing co-morbidities.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12872-022-02651-4","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:02:59Z","timestamp":1652166179000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mortality after transcatheter aortic valve replacement for aortic stenosis among patients with malignancy: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Muhammad Umer","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Yacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joey","family":"Junarta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed K.","family":"Pasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farouk","family":"Mookadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamas A.","family":"Mamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"18","key":"2651_CR1","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa1114705","volume":"366","author":"M Gilard","year":"2012","unstructured":"Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"2651_CR2","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.athoracsur.2003.08.049","volume":"77","author":"WP Mistiaen","year":"2004","unstructured":"Mistiaen WP, Van Cauwelaert P, Muylaert P, Wuyts F, Harrisson F, Bortier H. Effect of prior malignancy on survival after cardiac surgery. Ann Thorac Surg. 2004;77(5):1593\u20137 (discussion 7).","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"2651_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ahj.2011.03.013","volume":"161","author":"SW Yusuf","year":"2011","unstructured":"Yusuf SW, Sarfaraz A, Durand JB, Swafford J, Daher IN. Management and outcomes of severe aortic stenosis in cancer patients. Am Heart J. 2011;161(6):1125\u201332.","journal-title":"Am Heart J"},{"issue":"7","key":"2651_CR4","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cjca.2016.04.008","volume":"32","author":"CB Johnson","year":"2016","unstructured":"Johnson CB, Davis MK, Law A, Sulpher J. Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients. Can J Cardiol. 2016;32(7):900\u20137.","journal-title":"Can J Cardiol"},{"issue":"6","key":"2651_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2217\/fca.10.94","volume":"6","author":"F Mookadam","year":"2010","unstructured":"Mookadam F, Jalal U, Wilansky S. Aortic valve disease: preventable or inevitable? Future Cardiol. 2010;6(6):777\u201383.","journal-title":"Future Cardiol"},{"issue":"5","key":"2651_CR6","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BM Aleman","year":"2007","unstructured":"Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van\u2019t Veer MB, Baaijens MH, de Boer JP, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109(5):1878\u201386.","journal-title":"Blood"},{"issue":"4","key":"2651_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bjc.6605191","volume":"101","author":"T Wethal","year":"2009","unstructured":"Wethal T, Lund MB, Edvardsen T, Foss\u00e5 SD, Pripp AH, Holte H, et al. Valvular dysfunction and left ventricular changes in Hodgkin\u2019s lymphoma survivors. A longitudinal study. Br J Cancer. 2009;101(4):575\u201381.","journal-title":"Br J Cancer"},{"issue":"3","key":"2651_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jcmg.2015.06.028","volume":"9","author":"K Murbraech","year":"2016","unstructured":"Murbraech K, Wethal T, Smeland KB, Holte H, Loge JH, Holte E, et al. Valvular dysfunction in lymphoma survivors treated with autologous stem cell transplantation: a national cross-sectional study. JACC Cardiovasc Imaging. 2016;9(3):230\u20139.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2651_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jcin.2007.12.004","volume":"1","author":"BA Carabello","year":"2008","unstructured":"Carabello BA. Aortic stenosis: a fatal disease with but a single cure. JACC Cardiovasc Interv. 2008;1:127\u20138.","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"2651_CR10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.amjmed.2008.03.027","volume":"121","author":"S Sharma","year":"2008","unstructured":"Sharma S, Mehra A, Rahimtoola SH. Valvular heart disease: a century of progress. Am J Med. 2008;121(8):664\u201373.","journal-title":"Am J Med"},{"key":"2651_CR11","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.jacc.2007.08.011","volume":"50","author":"DS Bach","year":"2007","unstructured":"Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50:2018\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2651_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2651_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ije\/dys041","volume":"41","author":"RM Turner","year":"2012","unstructured":"Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012;41(3):818\u201327.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"2651_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"2651_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jclinepi.2017.12.004","volume":"97","author":"M Viswanathan","year":"2018","unstructured":"Viswanathan M, Patnode CD, Berkman ND, Bass EB, Chang S, Hartling L, et al. Recommendations for assessing the risk of bias in systematic reviews of health-care interventions. J Clin Epidemiol. 2018;97:26\u201334.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2651_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.amjcard.2016.05.052","volume":"118","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, et al. Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer. Am J Cardiol. 2016;118(4):572\u20137.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2651_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jcin.2018.10.026","volume":"12","author":"U Landes","year":"2019","unstructured":"Landes U, Iakobishvili Z, Vronsky D, Zusman O, Barsheshet A, Jaffe R, et al. Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis. JACC Cardiovasc Interv. 2019;12(1):78\u201386.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"2651_CR18","first-page":"105","volume":"30","author":"A Berkovitch","year":"2018","unstructured":"Berkovitch A, Guetta V, Barbash IM, Fink N, Regev E, Maor E, et al. Favorable short-term and long-term outcomes among patients with prior history of malignancy undergoing transcatheter aortic valve implantation. J Invasive Cardiol. 2018;30(3):105\u20139.","journal-title":"J Invasive Cardiol"},{"issue":"2","key":"2651_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/joic.12458","volume":"31","author":"N Mangner","year":"2018","unstructured":"Mangner N, Woitek FJ, Haussig S, Holzhey D, Stachel G, Schlotter F, et al. Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement. J Interv Cardiol. 2018;31(2):188\u201396.","journal-title":"J Interv Cardiol"},{"issue":"6","key":"2651_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/CIRCINTERVENTIONS.113.000409","volume":"6","author":"RJ Nuis","year":"2013","unstructured":"Nuis RJ, Sinning JM, Rod\u00e9s-Cabau J, Gotzmann M, van Garsse L, Kefer J, et al. Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013;6(6):625\u201334.","journal-title":"Circ Cardiovasc Interv"},{"key":"2651_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2020.03.038","volume":"315","author":"F Biancari","year":"2020","unstructured":"Biancari F, Dahlbacka S, Juvonen T, Virtanen MPO, Maaranen P, Jaakkola J, et al. Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement. Int J Cardiol. 2020;315:86\u20139.","journal-title":"Int J Cardiol"},{"issue":"10","key":"2651_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00392-017-1120-3","volume":"106","author":"S Bleiziffer","year":"2017","unstructured":"Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, et al. Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study. Clin Res Cardiol. 2017;106(10):784\u201395.","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"2651_CR23","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00392-020-01615-y","volume":"109","author":"N Tabata","year":"2020","unstructured":"Tabata N, Al-Kassou B, Sugiura A, Kandt J, Shamekhi J, Stundl A, et al. Prognostic impact of cancer history in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol. 2020;109(10):1243\u201350.","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2651_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ccd.28969","volume":"97","author":"AC Murphy","year":"2021","unstructured":"Murphy AC, Koshy AN, Cameron W, Horrigan M, Kearney L, Yeo B, et al. Transcatheter aortic valve replacement in patients with a history of cancer: periprocedural and long-term outcomes. Catheter Cardiovasc Interv. 2021;97(1):157\u201364.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"23","key":"2651_CR25","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.jacc.2013.01.090","volume":"61","author":"C Jaworski","year":"2013","unstructured":"Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61(23):2319\u201328.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2651_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2019-001131","volume":"7","author":"A Bendary","year":"2020","unstructured":"Bendary A, Ramzy A, Bendary M, Salem M. Transcatheter aortic valve replacement in patients with severe aortic stenosis and active cancer: a systematic review and meta-analysis. Open Heart. 2020;7(1): e001131.","journal-title":"Open Heart"},{"issue":"36","key":"2651_CR27","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768\u2013801.","journal-title":"Eur Heart J"},{"issue":"2","key":"2651_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ccd.22085","volume":"74","author":"RJ Cubeddu","year":"2009","unstructured":"Cubeddu RJ, Jneid H, Don CW, Witzke CF, Cruz-Gonzalez I, Gupta R, et al. Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: immediate, short- and long-term outcome at 2 years. Catheter Cardiovasc Interv. 2009;74(2):225\u201331.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"2651_CR29","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/0735-1097(95)00363-0","volume":"26","author":"EB Lieberman","year":"1995","unstructured":"Lieberman EB, Bashore TM, Hermiller JB, Wilson JS, Pieper KS, Keeler GP, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol. 1995;26(6):1522\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2651_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0145-2126(98)00126-X","volume":"23","author":"LE Samuels","year":"1999","unstructured":"Samuels LE, Kaufman MS, Morris RJ, Styler M, Brockman SK. Open heart surgery in patients with chronic lymphocytic leukemia. Leuk Res. 1999;23(1):71\u20135.","journal-title":"Leuk Res"},{"issue":"4","key":"2651_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1067\/mtc.2001.112823","volume":"121","author":"R Ascione","year":"2001","unstructured":"Ascione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini GD. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg. 2001;121(4):689\u201396.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2651_CR32","first-page":"13","volume":"82","author":"GJ Despotis","year":"1996","unstructured":"Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg. 1996;82(1):13\u201321.","journal-title":"Anesth Analg"},{"issue":"4","key":"2651_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1213\/01.ANE.0000081790.75298.D8","volume":"97","author":"BH Scott","year":"2003","unstructured":"Scott BH, Seifert FC, Glass PS, Grimson R. Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg. 2003;97(4):958\u201363 (table of contents).","journal-title":"Anesth Analg"},{"issue":"5","key":"2651_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.hlc.2012.02.004","volume":"21","author":"J Chan","year":"2012","unstructured":"Chan J, Rosenfeldt F, Chaudhuri K, Marasco S. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ. 2012;21(5):255\u20139.","journal-title":"Heart Lung Circ"},{"issue":"14","key":"2651_CR35","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.113.001435","volume":"127","author":"W Wu","year":"2013","unstructured":"Wu W, Masri A, Popovic ZB, Smedira NG, Lytle BW, Marwick TH, et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127(14):1476\u201385.","journal-title":"Circulation"},{"issue":"3","key":"2651_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ccd.27401","volume":"92","author":"JG Almeida","year":"2018","unstructured":"Almeida JG, Ferreira SM, Fonseca P, Dias T, Guerreiro C, Barbosa A, et al. Comparison of self-expanding and balloon-expandable transcatheter aortic valves morphology and association with paravalvular regurgitation: Evaluation using multidetector computed tomography. Catheter Cardiovasc Interv. 2018;92(3):533\u201341.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02651-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T08:36:13Z","timestamp":1700555773000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02651-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2651"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02651-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"25 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was a meta-analysis that did not require approval from our institutional review board. This article does not contain any studies with animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. The results presented in this paper have not been published previously in whole or part, except in abstract form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}